Abstract | OBJECTIVE: MATERIAL AND METHODS: Circulating DNP-LI was assessed in 19 normal human subjects and 19 patients with CHF (New York Heart Association class III or IV) with a specific and sensitive radioimmunoassay for DNP with no cross-reactivity with the other natriuretic peptides. Immunohistochemical studies that used polyclonal rabbit anti-DNP antiserum were performed on human atrial myocardial tissue obtained from four patients with end-stage CHF who were undergoing cardiac transplantation and from three donor hearts at the time of transplantation. RESULTS: We report that DNP-LI circulates in normal human plasma and is present in the normal atrial myocardium. In addition, DNP-LI is increased in the plasma of patients with CHF. CONCLUSION: This study demonstrates, for the first time, the presence of a DNP-like peptide in normal human plasma and in the atrial myocardium. Additionally, these studies demonstrate increased plasma DNP-LI in human CHF. These results support the possible existence of an additional new natriuretic peptide in humans, which may have a role in the neurohumoral activation that characterizes human CHF.
|
Authors | J A Schirger, D M Heublein, H H Chen, O Lisy, M Jougasaki, P W Wennberg, J C Burnett Jr |
Journal | Mayo Clinic proceedings
(Mayo Clin Proc)
Vol. 74
Issue 2
Pg. 126-30
(Feb 1999)
ISSN: 0025-6196 [Print] England |
PMID | 10069348
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Dendroaspis natriuretic peptide
- Elapid Venoms
- Immune Sera
- Intercellular Signaling Peptides and Proteins
- Peptides
|
Topics |
- Animals
- Case-Control Studies
- Elapid Venoms
(analysis, blood, chemistry, immunology)
- Heart Atria
(chemistry)
- Heart Failure
(blood, immunology)
- Humans
- Immune Sera
- Immunohistochemistry
- Intercellular Signaling Peptides and Proteins
- Peptides
(analysis, blood, chemistry, immunology)
- Rabbits
- Radioimmunoassay
- Severity of Illness Index
|